All CMT‐associated ARS enzymes (AARS, GARS, WARS, YARS, HARS) catalytically function as dimers, and disruption to the dimer functionality has been suggested as a mechanism of pathogenicity in ARS‐related CMT. This evidence concerns the gene HARS1 and Charcot-Marie-Tooth disease.